HopeStage
Back to all studies
CompletedNCT01562184

Investigating tDCS as a Treatment for Unipolar and Depression in bipolarity

Device studyAges 18+Australia + United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Atlanta and 5 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study clarity

Study information

Study start dateJune 2012
Recruitment status
Completed
Enrollment listed in the registry
120
Sponsor
The University of New South Wales
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States, Australia
Age range
Over 18 Years
Official registry ID
NCT01562184
Official title
Show the full official title

A Controlled Trial of Transcranial Direct Current Stimulation as a Treatment for Unipolar and Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Atlanta, United States · Towson, United States · Cherry Hill, United States

3 more locations
  • Durham, United States
  • Dallas, United States
  • Sydney, Australia
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of New South Wales, a university.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies